ALBERT DAVID
|
The Current P/S Ratio of ALBERT DAVID is 1.30.
| Share Price | ₹734.9 | Feb 16,2026 |
| Market Cap | ₹418.9 Cr | |
| Sales-TTM | ₹322.6 Cr | TTM-Standalone Results |
| Price/Sales | 1.30x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of ALBERT DAVID
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹418.9 Cr] as on Feb 16,2026
(/) Sales [ ₹322.6 Cr] based on TTM-Standalone Results
(=) P/S Ratio [ 1.30x ]
Thus, for ALBERT DAVID , the investors are currently willing to pay '1.30 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of ALBERT DAVID !
The chart below summarizes the trend in P/S Ratio of ALBERT DAVID over the last five years.
Historical PS (Price/Sales) ratio chart of ALBERT DAVID
PS Ratio Performance Analysis for ALBERT DAVID
- ALBERT DAVID 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 1.15x.
- ALBERT DAVID 's operated at median p/e ratio of 0.97x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, ALBERT DAVID 's p/e ratio peaked in Mar2024 at 1.69x.
- ALBERT DAVID 's p/e ratio hit its five-year low in Mar2023 of 0.86x.
How does ALBERT DAVID 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| ALBERT DAVID | 322.6 | 1.30 | 418.9 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 56,809.1 | 7.18 | 407,827.0 |
| DIVIS LABORATORIES LTD | 10,314.0 | 15.84 | 163,363.0 |
| CIPLA LTD | 28,351.1 | 3.86 | 109,519.0 |
| TORRENT PHARMACEUTICALS LTD | 12,742.0 | 11.32 | 144,193.0 |
| DR REDDYS LABORATORIES LTD | 34,682.2 | 3.05 | 105,940.0 |
| MANKIND PHARMA LTD | 13,914.1 | 6.18 | 85,946.0 |
| ZYDUS LIFESCIENCES LTD | 26,089.3 | 3.51 | 91,567.3 |
| LUPIN LTD | 26,150.5 | 3.88 | 101,486.0 |
| AUROBINDO PHARMA LTD | 33,181.9 | 2.07 | 68,819.2 |
| ABBOTT INDIA LTD | 6,824.1 | 8.20 | 55,934.9 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs ALBERT DAVID 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 1.30x |
| Max industry PS | 15.84x |
| Median industry PS | 3.88x |
| Average industry PS | 6.04x |
You may also like the below Video Courses